Let’s take the shortest path to discovery, together

Partner with us

Helping you solve the hardest problems in early discovery

MassAffinity collaborates with the pharmaceutical and biotechnology sector to accelerate early-stage discovery and uncover treatments that traditional methods often miss.

“We chase the targets others consider impossible”

Tamara Mills, CEO

Unlock undruggable targets

Reveal interactions that elude traditional assays and purification techniques.

Turn predictions into progress

Rapidly validate AI-driven or emerging hits with unambiguous results.

See biology in context

Capture binding events and complex behaviour in systems that preserve native biology.

Prioritise with confidence

Move beyond binary readouts with data that helps rank compounds and next-step experiments.

Ready to explore a project?

Let’s talk about how we can help you move from complexity to clarity — and from insight to impact.

This field is for validation purposes and should be left unchanged.

For inquiries, feedback, or collaboration opportunities email:

[email protected]